MRI Contrast Media Agents Market To Reach $4.33 Billion By 2033

MRI Contrast Media Agents Market Growth & Trends

The global MRI contrast media agents market size is expected to reach USD 4.33 billion by 2033, registering a CAGR of 7.15% from 2026 to 2033, according to a new report by Grand View Research, Inc. The factors anticipated to propel the growth include the rising prevalence of chronic diseases and the rising demand for early diagnosis. It is anticipated that the increasing number of clinical trials to determine the efficacy and efficiency of MRI contrast media agents in various clinical applications will spur market expansion.

According to WHO, chronic diseases will account for three-quarters of all deaths worldwide by 2020. Prevention of chronic diseases is possible if patients are diagnosed and treated early. However, to date, only four companies, Bayer AG, GE Healthcare LLC, Guerbet GmbH, and Bracco Imaging SpA are actively involved in the manufacture of MRI contrast agents, which creates tremendous opportunities for small businesses as well as the largest organization.

The early diagnosis of chronic diseases, such as cancer, cardiac diseases, and neurological disorders, significantly increases prognosis by enabling on-time treatment. Cancer and cardiovascular diseases together result in the highest global mortality rate. This has captured the attention of various governments & healthcare organizations and is driving them to work toward creating awareness regarding these diseases.

Companies like Miltenyi Biotec B.V. & Co. Kg, Reveal Pharma, and others have developed contrast media agents and are currently in the preclinical stage. The efficacy, safety, and in vivo compatibility of contrast agent makes them critical for receiving FDA approval. Several government initiatives to develop modern healthcare centers and also provide financial support for new MRI machines are driving the growth of the MRI contrast media agents industry. However, the reduction in diagnostic scans during the COVID-19 pandemic, the halt of logistics, and the development of generic products contributed to a decline in the market in 2020 and 2021. However, it is expected to bounce back by late 2022.

 Request a free sample copy or view report summary: MRI Contrast Media Agents Market Report

MRI Contrast Media Agents Market Report Highlights

• By product, the paramagnetic agents segment led the market with the largest revenue share in 2025 and are also expected to grow the fastest in the forecast period.

• By type, the clinical segment led the market with the largest revenue share in 2025 and is also expected to grow fastest in the forecast period.

• By application, the neurological imaging segment led the market with the largest revenue share in 2025 and is also expected to grow fastest in the forecast period.

• By end-use, the hospitals dominated the MRI contrast media/agents market in 2025 and are also expected to grow fastest in the forecast period.

• North America dominated the MRI contrast media agents market with the largest revenue share of 35.92% in 2025. The MRI contrast media agents market in the U.S. accounted for the largest market revenue share in North America in 2025.

MRI Contrast Media Agents Market Segmentation

Grand View Research has segmented global MRI contrast media agents market report on the basis of product, type, application, end-use, and region:

MRI Contrast Media Agents Product Outlook (Revenue, USD Million, 2021 - 2033)

• Paramagnetic Agents

• Superparamagnetic Agents

MRI Contrast Media Agents Type Outlook (Revenue, USD Million, 2021 - 2033)

• Clinical

• Preclinical

MRI Contrast Media Agents Application Outlook (Revenue, USD Million, 2021 - 2033)

• Gastrointestinal

• Intravenous

• Hepatobiliary

• Neurological Imaging

• Others

MRI Contrast Media Agents End-use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals

• Imaging Centers

MRI Contrast Media Agents Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the MRI Contrast Media Agents Market

• GE Healthcare

• Bayer AG

• Guerbet GmbH

• Bracco Imaging Spa

• Vitalquan, LLC

• Miltenyi Biotec B.V. & Co. Kg

• Beijing Beilu Pharmaceutical Co., Ltd.

• JB Pharma